Indian contract pharmaceutical manufacturer Kemwell Biopharma has appointed Dr Ninad Deshpanday as President of Research and Development.
Deshpanday has more than 22 years of diverse international experience in the pharmaceutical industry in the US and India.
Prior to joining Kemwell, he was President of Pharmaceutical R&D at Lupin, India. Before this he was Vice President of Business Development at AAIPharma in the US; Vice President for Drug Product Development at Synta Pharmaceuticals; and Technical Business Director for the Pharmaceutics division of Cardinal Health.
Anurag Bagaria, Chairman and Managing Director of Kemwell said: ‘Dr Deshpanday brings a unique combination of leadership skills and technical expertise in pharmaceutical development, as well as excellent business development skills with a very strong network of customers in the US, Europe and Asia. He will spearhead the R&D business for Kemwell as we continue to grow the geographical footprint and strategically position Kemwell into a leading Global Contract Services Provider.’
